Stock data

皇將 (4744)

皇將 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$107.83M, down 14.6% from a year earlier. EPS over the last four quarters totals NT$1.61.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 皇將 in Insightr